Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial.

ABSTRACT: Substance use is a frequent problem in schizophrenia, and although many substance misusing patients with the disorder also experience considerable cognitive impairments, such individuals have been routinely excluded from clinical trials of cognitive remediation that could support their functional and addiction recoveries. This study conducted a small-scale feasibility trial of Cognitive Enhancement Therapy (CET) in substance misusing schizophrenia patients to assess the feasibility and efficacy of implementing comprehensive neurocognitive and social-cognitive remediation in this population. A total of 31 schizophrenia outpatients meeting addiction severity criteria for alcohol and/or cannabis use were randomized to 18months of CET or usual care. Feasibility findings indicated high degrees

SUBMITTER: Eack SM 

PROVIDER: S-EPMC4308498 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature